Helix BioPharma Corp. - Financial and Strategic Analysis Review

Find Industry reports, Company profiles
ReportLinker and Market Statistics

>> Get this Report Now by email!

Helix BioPharma Corp. - Financial and Strategic Analysis Review
Published on July 2009

Report Summary


Summary

Helix BioPharma Corp. (Helix) is a biopharmaceutical company engaged in developing innovative products for the prevention and
treatment of cancer. The company is concentrating on the development of two clinical stage drugs with precise cancer applications;
L-DOS47 for lung adenocarcinoma and Topical Interferon Alpha-2b for low-grade squamous intraepithelial cervical lesions and
ano-genital warts. The company distributes drug products in Canada through its subsidiary Rivex Pharma Inc. Helix is headquartered
in Ontario, Canada

Global Markets Direct's Helix BioPharma Corp. - Financial and Strategic Analysis Review is an in-depth business, strategic and
financial analysis of Helix BioPharma Corp.. The report provides a comprehensive insight into the company, including business
structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of
the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

- Provides key company information for business intelligence needs.
- The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational
factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are
highlighted.
- The report contains critical company information ' business structure and operations, the company history, major products and
services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

- A quick 'one-stop-shop' to understand the company.
- Enhance business/sales activities by understanding customers' businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers ' with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company's financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Helix BioPharma Corp. - Financial and Strategic Analysis Review Page 1/5


Table of Content

Table of Contents
Table of Contents 2
List of Tables 2
List of Figures 2
Helix BioPharma Corp. - Key Facts 3
Helix BioPharma Corp. - Business Description 3
Helix BioPharma Corp. - Major Products and Services 4
Helix BioPharma Corp. - History 4
Helix BioPharma Corp. - SWOT Analysis 5
SWOT Analysis - Overview 5
Helix BioPharma Corp. - Strengths 5
Strength - Focused Research and Development Activities 5
Strength - Global Presence 5
Strength - Increased Revenues 5
Helix BioPharma Corp. - Weaknesses 5
Weakness - Concentrated Revenues from Canada 5
Weakness - Dependence on Strategic Relationships 5
Weakness - Low Return on Equity 5
Helix BioPharma Corp. - Opportunities 5
Opportunity - New Products in Pipeline 5
Opportunity - HPV Infections 6
Opportunity - Lung Cancer Market 6
Helix BioPharma Corp. - Threats 6
Threat - Stringent Regulations 6
Threat - Intense Competition 6
Threat - Product Liability Claims 6
Helix BioPharma Corp. - Key Competitors 7
Helix BioPharma Corp. - Key Employees 7
Helix BioPharma Corp. - Key Employee Biographies 8
Helix BioPharma Corp. - Company Statement 9
Helix BioPharma Corp. - Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Helix BioPharma Corp. - Financial Ratios 11
Financial Ratios - Capital Market Ratios 11
Financial Ratios - Annual Ratios 11
Financial Ratios - Interim Ratios 12
Financial Ratios - Ratio Charts 13
Appendix 14
Methodology 14
Ratio Definitions 14
About Global Markets Direct 17
Contact Us 17
Disclaimer 17
List of Tables



Helix BioPharma Corp., Key Facts 3
Helix BioPharma Corp., Major Products and Services 4
Helix BioPharma Corp., History 4
Helix BioPharma Corp., Key Employees 7
Helix BioPharma Corp., Key Employee Biographies 8
Helix BioPharma Corp., Subsidiaries 10
Helix BioPharma Corp., Ratios based on current share price 11
Helix BioPharma Corp., Annual Ratios 11
Helix BioPharma Corp., Interim Ratios 12
List of Figures
Helix BioPharma Corp., Ratio Charts 13



Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

Digital Copy--USD 125.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________



Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Helix BioPharma Corp. - Financial and Strategic Analysis Review

Recommandé

Recommandé

Contenu connexe

En vedette

En vedette (9)

Plus de ReportLinker.com

Plus de ReportLinker.com (20)

Dernier

Dernier (20)

Helix BioPharma Corp. - Financial and Strategic Analysis Review